Traumadornase: a Prospective, Randomized Multicenter, Double Blind Clinical Trial Comparing Inhaled Dornase Alfa and Its Placebo to Reduce the Incidence of Moderate to Severe ARDS in Ventilated Trauma Patients in the Intensive Care Unit
Phase of Trial: Phase III
Latest Information Update: 22 Aug 2019
Price : $35 *
At a glance
- Drugs Dornase alfa (Primary)
- Indications Adult respiratory distress syndrome
- Focus Therapeutic Use
- Acronyms TRAUMADORNASE
- 20 Aug 2019 Status changed from not yet recruiting to recruiting.
- 09 Jan 2019 Planned initiation date changed from 1 Nov 2018 to 1 Mar 2019.
- 24 Aug 2018 Planned initiation date changed from 1 Sep 2018 to 1 Nov 2018.